{"id":845469,"date":"2025-05-01T16:06:28","date_gmt":"2025-05-01T20:06:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/"},"modified":"2025-05-01T16:06:28","modified_gmt":"2025-05-01T20:06:28","slug":"aura-biosciences-to-participate-in-upcoming-investor-conferences-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/","title":{"rendered":"Aura Biosciences to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, May  01, 2025  (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc.\u00a0(NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that\u00a0members of its\u00a0senior management team will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>The Citizens Life Sciences Conference on Thursday, May 8, 2025.<br \/><\/strong>Fireside Chat at 9:30 a.m. ET.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 20, 2025.<br \/><\/strong>Fireside Chat at 2:00 p.m. ET.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>TD Cowen 6th Annual Oncology Innovation Summit on Tuesday, May 27, 2025.<br \/><\/strong>Fireside Chat at 10:00 a.m. ET.<\/p>\n<\/li>\n<\/ul>\n<p>The live webcasts of the fireside chats will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=b0m15iAg4udAfQTtADK08tJ7v3EVfgSsIOdDNYgHxPiGCMspLLZRPoDcxsUCYiO-hnEmQH1LEIvVd8FIeKLRV21t8JGB4QFMKXpQo--HyfHnHLfP181ziTsyGCwbWFeGJ3YDktEPqHwMl-ckYQakhu-LDQ1WWShSW3riXpVfvla9pJfxzDnEkSHIeh7e4QosSvuMp4QsEz-kzMXPntSkJDEdzruFVNrpnRY1j5KdQIIKZcDxOPXwTCKiKdNH-z9dwlxveOZOWFUY_0BDlnwQ3zkL-g23i_l3KKGM44_kRJvf7ljpgb3TiAy_ajlNrZPtuo2krlnDwOminENHVMFehEiY2qQHgWpMrcZqM-0CKgWOcK_IX9V-m-IVV-r_eaw9M_pahgYbYr4ae3Ug6BVF-xTFEp_nSg-BDtV8XaK89tMJ9UNIP7BntPe4Iu-tKbXyDabgJaY4waMT4mPdvUOrVYBVNIhDA8QuDfEW335fpjNs5CGgxQBAK1FJPOpNIQzwHBlf2zhw6tXeuMfYk_Gswg8REwYrNkinPs_Ri0CMGmZzQEuGJQAQAsSpJy38dwqfnHNRy_jDGiuoEsxispxXY4fYNfSb2_G5dxoHR1C6wcXzpKIb6OUWc6qfN3FGMB3z8MopNMpjCv1tSAlycBzUJeByqUMxhrmCjpKhdp2z7rZz8IL_y09q5BYPFO9s2LFxoxMaMXTGuA_gCS6BgqOR1lJ-_o7voh2rQjYaY2NZTR3PfdXyWBzQi-sOtF7fZjE1ipxzoPWGqFZiPk0YNMjObsuIlsR5RVV0_Vf8_M_seEIttl2toKdn63Lm4QDuY0YmuZyxZMbI3oaz7WK-4S73owWy_tuLhZlicDGPwxX5XNF-GN5KU7Zmvh833OCIwPrP-UToNqjEDtqY_MEUkJEFA6bsiF5YNhukHPichSwvW25i5_TbWzysnGmmHoPt1pV-Bkjsz7eIhnSQv7KRcEWmtP0HgLNflA2RyWSkxAIbDbX8fXv8vou1JK0XrHfg2EadVkFTnktMSeNhoo0dwzuZOlIqDDirsX2eta1Dxr3Q7rDuUcqSi4CI2YMJ0bxXQKo3sPmPrX14JF8X6LHiCzI-ZgvEcgkIrBBltf3wg7M2r6cxetZyfE0Ks5TuBHPobuor7ofUDew9-CMcP1HuvLmU3RaylsYfXE1-ubpe4K9DXOF4hMf4-C2MJZuKGpavrSuNNGolIJgkXbarTZ3jeo2eTOGBoncq65ub4V_6_r84I7jnrKf_s21FTZklVUitx5Do\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.aurabiosciences.com\/events-and-presentations<\/a>, where a replay of each webcast will be archived for 90 days following the presentation date.<\/p>\n<p>\n        <strong>About\u00a0Aura Biosciences<\/strong>\n      <\/p>\n<p>Aura Biosciences\u00a0is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for primary choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer.\u00a0Aura Biosciences\u00a0is headquartered in\u00a0Boston, MA.\u00a0Our mission is to grow as an innovative global oncology company that positively transforms the lives of patients.<\/p>\n<p>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Aeq_SHfQPHf86WOmYnqMS67S-65R0AvcG6Ra-cUs_pbZ2A4AfjoZcuteRZw_wLIo7WbWti8NDrVzuWrh4aH6MUY1uW_gnR6P28L_B5mptODGCxvCb-XH408vXMzFnaKS-uFUKgyZ1ZybcdaAH47-35YamACkb-HPTw-v8JQyx-gPwqxuuBjbcOTtoKaJzjDVaj56Y9OweUIxxiFJz5bvB-17z9qwiHC1hfZb72cRU813MiGnK_4Ut_5R9loMzokNQhnkHBUtcG4q5h3WIn8ofw==\" rel=\"nofollow\" target=\"_blank\">aurabiosciences.com<\/a>. Follow us on X (formerly Twitter) @AuraBiosciences and visit us on LinkedIn.<\/p>\n<p>\n        <strong>Investor and Media Contact:<\/strong>\n      <\/p>\n<p>Alex Dasalla<br \/>Head of Investor Relations and Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Hw_Xm9-GphrH9IjYxkRusEJTpua6VOM9sw73BO78nehWFPNjbSPzGq6jVSKeKF11yfbOtjSy7GQ0DrdHNcx0FeKFOY-IBHqLPAH9ROZyG3ynrIOHSHW6M65J7RMllvgHTJ5sIaaBNpy8JgaU91ccUH-LJ-4ih3GXGQlmMGU7q9G4geB8yBCaEChYYXyAf4O1N9YHsNKEgMIDvrffmKTYSkk7619eRwssBO9Oj5PT5TvhexUOlGQxwalJKY328YkuK6L1_jElRbHCH4hxzwpLvr_GmzS-3fAqs3vw-kShewXpfP01nUUMYum1RAMQJT22JyF32mH0na44Bu4iHaqN81lEapEVGQ60am406ai0hcqEHKHgye2nU42bSVyg3ahijsmnghOmpXoOGHO5noXKlbisxhZdvj16nFaudkMFpCh2A_ml9jaVuPfMI54_T7LCaQkLst1CuQguq7TUp6H7OSrV3sX03kQBZZbmERs8fo6N6HWHtj09r8Yd4CPihgWF\" rel=\"nofollow\" target=\"_blank\">IR@aurabiosciences.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjExMzkzYTUtYTI3YS00NTk2LTgxMDktYjc4NTI0YmU5YTU2LTUwMDEyNDI2MC0yMDI1LTA1LTAxLWVu\/tiny\/Aura-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, May 01, 2025 (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc.\u00a0(NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that\u00a0members of its\u00a0senior management team will participate in the following upcoming investor conferences: The Citizens Life Sciences Conference on Thursday, May 8, 2025.Fireside Chat at 9:30 a.m. ET. H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 20, 2025.Fireside Chat at 2:00 p.m. ET. TD Cowen 6th Annual Oncology Innovation Summit on Tuesday, May 27, 2025.Fireside Chat at 10:00 a.m. ET. The live webcasts of the fireside chats will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0https:\/\/ir.aurabiosciences.com\/events-and-presentations, where &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aura Biosciences to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-845469","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aura Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aura Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, May 01, 2025 (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc.\u00a0(NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that\u00a0members of its\u00a0senior management team will participate in the following upcoming investor conferences: The Citizens Life Sciences Conference on Thursday, May 8, 2025.Fireside Chat at 9:30 a.m. ET. H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 20, 2025.Fireside Chat at 2:00 p.m. ET. TD Cowen 6th Annual Oncology Innovation Summit on Tuesday, May 27, 2025.Fireside Chat at 10:00 a.m. ET. The live webcasts of the fireside chats will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0https:\/\/ir.aurabiosciences.com\/events-and-presentations, where &hellip; Continue reading &quot;Aura Biosciences to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-01T20:06:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aura Biosciences to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2025-05-01T20:06:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/\"},\"wordCount\":255,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/\",\"name\":\"Aura Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==\",\"datePublished\":\"2025-05-01T20:06:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aura Biosciences to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aura Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/","og_locale":"en_US","og_type":"article","og_title":"Aura Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"BOSTON, May 01, 2025 (GLOBE NEWSWIRE) &#8212; Aura Biosciences, Inc.\u00a0(NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that\u00a0members of its\u00a0senior management team will participate in the following upcoming investor conferences: The Citizens Life Sciences Conference on Thursday, May 8, 2025.Fireside Chat at 9:30 a.m. ET. H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ on Tuesday, May 20, 2025.Fireside Chat at 2:00 p.m. ET. TD Cowen 6th Annual Oncology Innovation Summit on Tuesday, May 27, 2025.Fireside Chat at 10:00 a.m. ET. The live webcasts of the fireside chats will be available on the \u201cInvestors &amp; Media\u201d page under the \u201cEvents &amp; Presentations\u201d section of the Company\u2019s website at\u00a0https:\/\/ir.aurabiosciences.com\/events-and-presentations, where &hellip; Continue reading \"Aura Biosciences to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-01T20:06:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aura Biosciences to Participate in Upcoming Investor Conferences","datePublished":"2025-05-01T20:06:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/"},"wordCount":255,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/","name":"Aura Biosciences to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==","datePublished":"2025-05-01T20:06:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MzAwOSM2OTE2ODAzIzUwMDEyNDI2MA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aura-biosciences-to-participate-in-upcoming-investor-conferences-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aura Biosciences to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/845469","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=845469"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/845469\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=845469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=845469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=845469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}